Showing results (181-190 of 211) with videos related to

Sort By:
Pageof 22
Radiation Oncology (London, England)|January 4, 2025
Single-arm multicenter phase II study on aggressive local consolidative therapy in combination with systemic chemotherapy for stage IV non-small cell lung carcinoma with oligometastases: CURE-OLIGO (TORG1529)Takaaki Tokito, Kazuhiko Yamada, Hidenobu Ishii, et al.
Translational Cancer Research|May 14, 2023
Multicenter, single-arm phase II study of modified carboplatin/nab-paclitaxel in untreated performance status 2 patients with advanced non-small cell lung cancer: TORG1426Yasuko Ichikawa, Nobuhiko Seki, Takeshi Honda, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agentsMakako Yamanaka, Yuji Tada, Kiyoko Kawamura, et al.
Annals of the American Thoracic Society|February 16, 2024
Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary FibrosisSatoshi Ikeda, Takashi Ogura, Terufumi Kato, et al.
JTO Clinical and Research Reports|June 12, 2023
Survival Impact of Second-Line Immune Checkpoint Inhibitors in Older Patients With Advanced Squamous-Cell NSCLC: Post Hoc Analysis of the CAPITAL StudyYoshihito Kogure, Akiko Kada, Hiroya Hashimoto, et al.
Japanese Journal of Clinical Oncology|April 10, 2024
A single arm Phase I/II trial on the combination of carboplatin, nab-paclitaxel and avastin as first-line treatment for advanced non-squamous non-small cell lung cancer (TORG1424/OLCSG1402: CARNAVAL)Naoyuki Nogami, Toshio Kubo, Akihiro Bessho, et al.
Respiratory Investigation|December 3, 2014
Current status and future perspectives of cooperative study groups for lung cancer in JapanYuko Kawano, Isamu Okamoto, Haruhiko Fukuda, et al.
Anticancer Research|December 6, 2015
Multicenter Phase II Study of Nedaplatin and Irinotecan for Patients with Squamous Cell Carcinoma of the Lung: Thoracic Oncology Research Group 0910Kouzo Yamada, Haruhiro Saito, Tetsuro Kondo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2022
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2006
Phase II trial of amrubicin for treatment of refractory or relapsed small-cell lung cancer: Thoracic Oncology Research Group Study 0301Sayaka Onoda, Noriyuki Masuda, Takashi Seto, et al.
Pageof 22